The Skin Therapy Research Unit (STRU) at King's is a dermatology research and clinical trials facility based at St John’s Institute of Dermatology within Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London.
Founded in 1996 the Unit provides a range of services to both patients and health-care professionals carried out by a team of dedicated specialist doctors and nurses. The ultimate goal of our research is to improve patient care and treatment.
The Unit investigates the genetic basis of many common skin diseases, with particular focus in psoriasis, eczema, acne and severe drug eruptions.
The Unit also works in partnership with the pharmaceutical industry to establish and monitor, a number of Phase II, III and IV clinical trials of therapeutic interventions for all skin conditions, evaluating the safety and effectiveness of the treatments.
In addition to the above, the Unit also runs specialist monitoring services for patients who need systemic therapies for their skin diseases (such as patients on Methotrexate, Cyclosporine, Acitretin, Etanercept and Infliximab, Adalimumab, Ustekinumab and Secukinumab) as well as offering tailor-made dermatology training sessions to healthcare professionals and pharmaceutical companies involved in drug development and clinical trial design.
There are many clinical research opportunities available through STRU. Find out more about the work of each of our research groups.
- To carry out high quality clinical research into skin diseases.
- To provide dedicated clinical staff and a patient-orientated environment.
- To gain a better understanding of the causes and nature of common skin diseases.
- To adhere to the principles of GCP at all times.
- Dermatology research and clinical trials unit
- Research Nurses
- Administrative staff